Report overview
This report aims to provide a comprehensive presentation of the global market for Small Molecule Targeted Anti-cancer Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Small Molecule Targeted Anti-cancer Drug. This report contains market size and forecasts of Small Molecule Targeted Anti-cancer Drug in global, including the following market information:
Global Small Molecule Targeted Anti-cancer Drug Market Revenue, 2018-2023, 2024-2030, ($ millions)
Global top five companies in 2022 (%)
The global Small Molecule Targeted Anti-cancer Drug market was valued at US$ million in 2022 and is projected to reach US$ million by 2030, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
EGFR Segment to Reach $ Million by 2030, with a % CAGR in next six years.
The global key manufacturers of Small Molecule Targeted Anti-cancer Drug include Astrazeneca, Novartis, Millennium Pharmaceuticals, Bayer, Exelixis, Abbvie, Boehringer-Ingelheim, Eisai and Pfizer, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Small Molecule Targeted Anti-cancer Drug companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Small Molecule Targeted Anti-cancer Drug Market, by Type, 2018-2023, 2024-2030 ($ millions)
Global Small Molecule Targeted Anti-cancer Drug Market Segment Percentages, by Type, 2022 (%)
EGFR
ALK
Bcr-Abl
Others
Global Small Molecule Targeted Anti-cancer Drug Market, by Application, 2018-2023, 2024-2030 ($ millions)
Global Small Molecule Targeted Anti-cancer Drug Market Segment Percentages, by Application, 2022 (%)
Liver Cancer
Colorectal Cancer
Lung Cancer
Gastric Cancer
Breast Cancer
Esophageal Cancer
Others
Global Small Molecule Targeted Anti-cancer Drug Market, By Region and Country, 2018-2023, 2024-2030 ($ Millions)
Global Small Molecule Targeted Anti-cancer Drug Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Small Molecule Targeted Anti-cancer Drug revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Small Molecule Targeted Anti-cancer Drug revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Astrazeneca
Novartis
Millennium Pharmaceuticals
Bayer
Exelixis
Abbvie
Boehringer-Ingelheim
Eisai
Pfizer
Bristol-Myers Squibb
Roche
Bettapharma
Outline of Major Chapters:
Chapter 1: Introduces the definition of Small Molecule Targeted Anti-cancer Drug, market overview.
Chapter 2: Global Small Molecule Targeted Anti-cancer Drug market size in revenue.
Chapter 3: Detailed analysis of Small Molecule Targeted Anti-cancer Drug company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Small Molecule Targeted Anti-cancer Drug in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
